Lucentis (ranibizumab) is a brand-name eye injection that’s prescribed for certain eye conditions in adults. As with other drugs, Lucentis can cause side effects, such as eye pain or irritation. More ...
Lucentis ® (ranibizumab) is the first licensed therapy to improve vision in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia Pivotal trial shows ...
Lucentis Safety Lucentis is a prescription medication given by injection into the eye, and it has side effects. Some Lucentis patients have had detached retinas and serious infections inside the eye.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Lucentis is approved for wet age-related macular degeneration (AMD) in over 100 countries. It is also approved for the treatment of visual impairment due to diabetic macular edema (:DME) and macular ...
A real-world PMS study based on a large population demonstrates comparable safety profile of SB11 (BYOOVIZ ® / AMELIVU ® ) to reference ...
Lucentis is FDA-approved for the treatment of patients with wet age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic ...
A landmark study by the National Institutes of Health determines that Lucentis is highly effective as a treatment for diabetic retinopathy. Compared with laser therapy for the treatment of ...
Medicare, the federal health insurance program for Americans 65 and older, could save $18 billion over the next 10 years if doctors switch to a less expensive drug to treat blindness. The switch could ...
Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "LUCENTIS Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report delivers insights into LUCENTIS's ...
Lucentis, known generically as ranibizumab, is the only drug approved by the Food and Drug Administration for treating the wet form of age-related macular degeneration, commonly known as AMD. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results